IMTX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Immatics NV · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 8.66 USD
-4.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -13.7% below the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned -4.6%, after a -13.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 44/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 10d.

Setup score 31 out of 100
Latest Close 8.66 USD 31 Jul 2026
1W Return -4.6% latest completed week
4W Return -13.0% short-term follow-through
12W Return -23.8% quarterly tape
Trend Breadth 86.5% 45 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.6% Latest completed week; four-week move -13.0%. Indicator stack 48/25 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 44/100 conviction; expected move 3.2%. News sentiment 52/100 57 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.7% below the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned -4.6%, after a -13.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3912-week average 0.59

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.39Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.0% over four weeks, -23.8% over 12 weeks, and 33.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.6%
4W-13.0%
12W-23.8%
26W-9.3%
52W33.6%
Active trend streak0 weeks
Active weeks in one year45
Trend breadth86.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.21Latest activity-pressure read.
Pressure change-43.2%Four-week change in activity pressure.
Leadership-15.95Latest relative-leadership reading.
RS change-175.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength16/100Blend of value, momentum, and quality. Underlying universe rank 85; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
33.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-18.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
100.0%
Gross profit retained from each unit of revenue.
Operating margin
-574.9%
Operating profit retained from revenue.
Free-cash-flow margin
-482.0%
Free cash flow generated from revenue.
Return on invested capital
-94.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-74.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-10.4%
Net share repurchases relative to market value.
Shareholder yield
-10.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

IMTX shows bullish options pressure with a 44/100 conviction score, put-call volume ratio of 0.00, expected move of 3.2%, and Sharemaestro trend signal inactive.

Conviction44/100
Expected move3.2%
Put/call volume0.00
Pressure100
Speculation1
Volatility22
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 57 relevant articles.

13 positive · 37 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move3.2%Nearest-chain priced movement where available.
52-week drawdown-30.2%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+10.5%Week of 3 Apr.
Worst week-14.9%Week of 5 Jun.
Latest week-4.6%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses5
Sharp losses8
Recent vol5.6%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew6.4% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis39/100

Latest 12-week confirmation: trend 5/12, activity pressure 5/12, relative leadership 3/12.

Activity pressure 0.39; No reversal markers Factors28/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 87; Small Cap Core rank 85 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options44/100

IMTX shows bullish options pressure with a 44/100 conviction score, put-call volume ratio of 0.00, expected move of 3.2%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 3.2% Sentiment52/100

Weighted news tone is neutral across 57 relevant articles.

Immatics (NASDAQ:IMTX) Sees Strong Trading Volume - Here's What Happened Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20268.66 USD-4.6%10.04 USD9.21 USD-1.21-15.953.2MOff
24 Jul 20269.08 USD-5.3%10.10 USD9.23 USD-1.14-11.291.2MOff
17 Jul 20269.59 USD-0.9%10.13 USD9.25 USD-0.99-7.611.6MOff
10 Jul 20269.68 USD-2.7%10.16 USD9.27 USD-0.90-10.272.2MOff
3 Jul 20269.95 USD4.5%10.17 USD9.28 USD-0.85-5.781.8MOff
26 Jun 20269.52 USD-2.7%10.18 USD9.29 USD-0.65-8.652.1MOff
19 Jun 20269.78 USD4.3%10.22 USD9.30 USD-0.29-9.961.1MOff
12 Jun 20269.38 USD-4.2%10.23 USD9.31 USD0.13-11.041.9MOn
5 Jun 20269.79 USD-14.9%10.26 USD9.33 USD0.50-4.844.9MOn
29 May 202611.51 USD-0.9%10.23 USD9.34 USD0.767.211.7MOn
22 May 202611.62 USD6.9%10.19 USD9.33 USD0.7212.132.8MOn
15 May 202610.87 USD-4.4%10.14 USD9.32 USD0.667.043.2MOn
8 May 202611.37 USD5.4%10.11 USD9.32 USD0.6112.543.0MOn
1 May 202610.79 USD-4.9%10.07 USD9.31 USD0.2813.791.8MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.